[Federal Register Volume 63, Number 64 (Friday, April 3, 1998)]
[Notices]
[Page 16565]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-8815]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Cancer Institute Special Emphasis Panel (SEP) meetings:
Name of SEP: Pivotal Clinical Trials for Chemoprevention Agent
Development.
Date: April 15-16, 1998.
Time: April 15--7:00 p.m. to Recess; April 16--8:00 a.m. to
Adjournment.
Place: Double Tree Hotel--Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Rashmi Gopal-Srivastava, Ph.D., Scientific
Review Administrator, National Cancer Institute, NIH, Executive
Plaza North, Room 609, 6130 Executive Boulevard, MSC 7410, Bethesda,
MD 20892-7410, Telephone: 301/496-2378.
Purpose/Agenda: To evaluate and review grant applications.
The meetings will be closed in accordance with the provisions
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and the discussions could reveal confidential trade
secrets or commercial property such as patentable material and
personal information concerning individuals associated with the
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Program Numbers: 93.393,
Cancer Cause and Prevention Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer Treatment Research, 93.396,
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93.399, Cancer Control)
Dated: March 24, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-8815 Filed 4-2-98; 8:45 am]
BILLING CODE 4140-01-M
